Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Appfolio lost $3.2 million during the second quarter, the company reported Aug. 6. Goleta-based Appfolio makes property management software for small-to medium-sized real estate managers. Revenues were up 59 percent in the second quarter of 2015 from $11.6 million last year to $18.4 million this year. Appfolio lost 34 cents per share, which met analyst Read More →
San Luis Obispo-based Mindbody beat analyst estimates when it released second quarter earnings on Aug. 4, but shares still ended down for a ninth consecutive day. Mindbody lost 21 cents per share, but analysts had predicted losses of 31 cents per share. Mindbody’s surprising earnings are a rare recent bright spot for the company since Read More →
One of the biggest employers in Ventura County faces an ownership change less than one month after it was spun off from its Chicago-area parent. Shire Plc, a pharma company based in Dublin, Ireland, stunned the markets on Aug. 4 with a $30 billion bid for Baxalta. Baxalta, which employs around 2,000 at two locations Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta-based Deckers on July 30 reported a loss of $47.3 million in its fiscal first quarter and a loss of $1.43 on a per-share basis. Despite the per-share loss, the results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.51 per share. Deckers Read More →
